SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about unaudited financial results

01 Nov 2019 Evaluate

Ambalal Sarabhai Enterprises has informed that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019, to consider and take on record the unaudited financial results (Standalone and Consolidated) of the Company together with Limited Review Report of Auditors for quarter and half year ended 30.09.2019.

The above information is a part of company’s filings submitted to BSE.

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×